Cart
sales@molnova.com
Bucladesine sodium salt
CAS No. 16980-89-5
Bucladesine sodium salt ( Bucladesine sodium; DbcAMP sodium )
Catalog No. M18114 CAS No. 16980-89-5
Bucladesine, PKA activator, is a cyclic nucleotide derivative that mimics the action of endogenous cAMP and is capable of permeating the cell membrane.
Purity : 97%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 38 | In Stock |
|
| 100MG | 71 | In Stock |
|
| 200MG | 105 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBucladesine sodium salt
-
NoteResearch use only, not for human use.
-
Brief DescriptionBucladesine, PKA activator, is a cyclic nucleotide derivative that mimics the action of endogenous cAMP and is capable of permeating the cell membrane.
-
DescriptionBucladesine sodium is a cardiac stimulant.
-
SynonymsBucladesine sodium; DbcAMP sodium
-
PathwayOthers
-
TargetOther Targets
-
RecptorPKA
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number16980-89-5
-
Formula Weight491.37
-
Molecular FormulaC18H23N5NaO8P
-
Purity97%
-
SolubilityDMSO : 150 mg/mL 305.27 mM;H2O : ≥ 42 mg/mL 85.48 mM
-
SMILESCCCC(=O)NC1=NC=NC2=C1N=CN2C3C(C4C(O3)COP(=O)(O4)[O-])OC(=O)CCC.[Na+]
-
Chemical Namesodium (4aR,6R,7R,7aR)-6-(6-butyramido-9H-purin-9-yl)-7-(butyryloxy)tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-2-olate 2-oxide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
AS-604850
AS-604850 is a specific and ATP-competitive PI3Kγ inhibitor (IC50: 250 nM), 18-fold more selective for PI3Kγ than PI3Kα, and over 80-fold selectivity for PI3Kγ than PI3Kδ/β.
-
[Pyr1]-Apelin-13
[Pyr1]-Apelin-13 is a potent and selective endogenous Apelin receptor (APJ) agonist.[Pyr1]-apelin-13 encapsulation in lipoPEG particles (lipoPEG-PA13) results in sustained and extended drug release under physiological conditions[1].[Pyr1]-apelin-13 nanocarriers in a mouse model of pressure-overload induced heart failure demonstrate a sustainable long-term effect of [Pyr1]-apelin-13 in preventing cardiac dysfunction.
-
PACAP (1-27), human,...
PACAP (1-27), human, ovine, rat TFA (PACAP 1-27 TFA) is an N-terminal fragment of pacap-38 and an effective PACAP receptor antagonist. The IC50s for rat PAC1, rat VPAC1 and human VPAC2 are 3nm, 2nm and 5nm respectively.
